Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.89 USD | +5.19% |
|
-21.85% | +10.68% |
04/06 | Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target | MT |
24/05 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.68% | 41Cr | |
+15.85% | 12TCr | |
+18.91% | 11TCr | |
+4.43% | 2.28TCr | |
-18.63% | 2.07TCr | |
-13.76% | 1.64TCr | |
-16.61% | 1.65TCr | |
-43.53% | 1.58TCr | |
+1.75% | 1.35TCr | |
+28.07% | 1.17TCr |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.
- Cartesian Gets Regenerative Medicine Advanced Therapy Label for Myasthenia Gravis Drug Candidate